Fig. 6From: Modulation of Nucleotide Triphosphate Diphosphohydrolase-1 (NTPDase-1)/cd39 in Xenograft RejectionWestern analysis of cd39 expression in accommodated xenografts. (A) Western blotting of cd39+/+ accommodated grafts. (B) Mutant (cd39−/−) accommodated grafts. Increased levels of expression of cd39 are observed at 45 and 60 days within wild-type grafts only.Back to article page